Compare Abeona Therapeutics Inc (ABEO) vs Newmont Corporation (NEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Newmont Corporation — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Newmont Corporation trades at $119.18 (market cap $123.50B). The key difference: Newmont Corporation is far larger — about 293.2× Abeona Therapeutics Inc's market cap, and Newmont Corporation pays a 0.89% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | NEM | |
|---|---|---|
Market Cap | $421.19M | $123.50B |
Sector | Health | Basic Materials |
52-Week High | $7.45 | $131.95 |
52-Week Low | $4.17 | $67.38 |
Enterprise Value | $276.10M | $120.09B |
Dividend Yield | — | 0.89% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Newmont Corporation
Newmont Corp is primarily a gold producer with operations and/or assets in the United States, Canada, Mexico, Dominican Republic, Peru, Suriname, Argentina, Chile, Australia, and Ghana. It is also engaged in the production of copper, silver, lead and zinc. The company's operations are organized in five geographic regions: North America, South America, Australia, Africa and Nevada.
Read more on NEM →
